Actuate Therapeutics Inc (ACTU)

Dec 04, 2025

Will Actuate Therapeutics Inc. stock see PE expansionInsider Selling & Daily Chart Pattern Signal Reports - Newser

Dec 04, 2025

Dec 02, 2025

Why Actuate Therapeutics Inc. stock is a must watch in 2025Forecast Cut & AI Based Buy and Sell Signals - Newser

Dec 02, 2025

Nov 28, 2025

Actuate Therapeutics enters $100 million at-the-market sales agreement - Investing.com

Nov 28, 2025

Nov 28, 2025

Actuate Therapeutics Signs $100M Sales Agreement - TipRanks

Nov 28, 2025

Nov 28, 2025

Actuate Therapeutics Inc enters at the market issuance sales agreement with B. Riley and Craig-HallumSEC filing - marketscreener.com

Nov 28, 2025

Nov 28, 2025

How Much Upside is Left in Actuate Therapeutics, Inc. (ACTU)? Wall Street Analysts Think 214.06% - Zacks Investment Research

Nov 28, 2025

Nov 27, 2025

Why Actuate Therapeutics Inc. stock is recommended by analystsJuly 2025 Analyst Calls & Verified Technical Trade Signals - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

What risks investors should watch in Actuate Therapeutics Inc. stockOptions Play & Weekly Setup with ROI Potential - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

Actuate Therapeutics, Inc.'s (NASDAQ:ACTU) market cap surged US$24m last week, private equity firms who have a lot riding on the company were rewarded - simplywall.st

Nov 27, 2025

Nov 25, 2025

BIOS Capital Management LP Buys 71,428 Shares of Actuate Therapeutics, Inc. $ACTU - Defense World

Nov 25, 2025

Nov 25, 2025

What analysts say about Actuate Therapeutics Inc stockTrade Execution Strategies & Daily Tips From Top Market Analysts - earlytimes.in

Nov 25, 2025

Nov 24, 2025

Will Upside Catalysts Materialize for Prime Industries Limited in YEARHigh Frequency Trading Trends & Free Unlock Rapid Growth Potential - earlytimes.in

Nov 24, 2025

Nov 22, 2025

HC Wainwright Has Bullish Estimate for ACTU FY2025 Earnings - Defense World

Nov 22, 2025

Nov 20, 2025

Why Actuate Therapeutics Inc. stock is in analyst buy zoneEarnings Trend Report & Verified Entry Point Signals - newser.com

Nov 20, 2025

Nov 19, 2025

Actuate Therapeutics: Strategic Advancements and Financial Outlook Drive Buy Rating - TipRanks

Nov 19, 2025

Nov 19, 2025

HC Wainwright & Co. Reiterates Actuate Therapeutics (ACTU) Buy Recommendation - Nasdaq

Nov 19, 2025

Nov 17, 2025

How Actuate Therapeutics Inc. stock compares to market leadersEarnings Overview Report & Expert Approved Momentum Ideas - newser.com

Nov 17, 2025

Nov 16, 2025

Using R and stats models for Actuate Therapeutics Inc. forecastingRate Hike & Fast Gaining Stock Reports - newser.com

Nov 16, 2025

Nov 16, 2025

Strategies to average down on Actuate Therapeutics Inc.Quarterly Risk Review & Safe Capital Growth Stock Tips - newser.com

Nov 16, 2025

Nov 16, 2025

How Actuate Therapeutics Inc. stock benefits from tech adoptionTrade Volume Summary & Long-Term Growth Plans - newser.com

Nov 16, 2025

Nov 15, 2025

Advanced analytics toolkit walkthrough for Actuate Therapeutics Inc.July 2025 Short Interest & Weekly Return Optimization Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

Is it time to cut losses on Actuate Therapeutics Inc.July 2025 Update & High Yield Stock Recommendations - newser.com

Nov 15, 2025

Nov 15, 2025

Here's Why We're Watching Actuate Therapeutics' (NASDAQ:ACTU) Cash Burn Situation - Yahoo Finance

Nov 15, 2025

Nov 15, 2025

What indicators show strength in Actuate Therapeutics Inc.July 2025 Decliners & Advanced Technical Signal Analysis - newser.com

Nov 15, 2025

Nov 15, 2025

Actuate Therapeutics (NASDAQ:ACTU) Stock Price Up 0.5% on Better-Than-Expected Earnings - Defense World

Nov 15, 2025

Nov 14, 2025

Analysts Offer Insights on Healthcare Companies: Vicarious Surgical (RBOT) and Intensity Therapeutics, Inc. (INTS) - The Globe and Mail

Nov 14, 2025

Nov 13, 2025

Actuate Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 13, 2025

Nov 11, 2025

Analysts Offer Insights on Healthcare Companies: Tyra Bioscience (TYRA), Janux Therapeutics Inc (JANX) and Eledon Pharmaceuticals (ELDN) - The Globe and Mail

Nov 11, 2025

Nov 10, 2025

What’s next for Actuate Therapeutics Inc. stock priceJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com

Nov 10, 2025

Nov 09, 2025

Real time scanner hits for Actuate Therapeutics Inc. explained2025 Sector Review & Precise Swing Trade Alerts - newser.com

Nov 09, 2025

Nov 07, 2025

Is Actuate Therapeutics Inc. building a consolidation base2025 Trading Recap & AI Forecast for Swing Trade Picks - newser.com

Nov 07, 2025

Nov 07, 2025

Myelofibrosis Market is Expected to Flourish in 7MM, Expanding - openPR.com

Nov 07, 2025